Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Hum Genet
2014 Aug 01;1338:997-1009. doi: 10.1007/s00439-014-1444-2.
Show Gene links
Show Anatomy links
CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance.
Schulz Y
,
Wehner P
,
Opitz L
,
Salinas-Riester G
,
Bongers EM
,
van Ravenswaaij-Arts CM
,
Wincent J
,
Schoumans J
,
Kohlhase J
,
Borchers A
,
Pauli S
.
???displayArticle.abstract???
Heterozygous loss of function mutations in CHD7 (chromodomain helicase DNA-binding protein 7) lead to CHARGE syndrome, a complex developmental disorder affecting craniofacial structures, cranial nerves and several organ systems. Recently, it was demonstrated that CHD7 is essential for the formation of multipotent migratory neural crest cells, which migrate from the neural tube to many regions of the embryo, where they differentiate into various tissues including craniofacial and heart structures. So far, only few CHD7 target genes involved in neural crest cell development have been identified and the role of CHD7 in neural crest cell guidance and the regulation of mesenchymal-epithelial transition are unknown. Therefore, we undertook a genome-wide microarray expression analysis on wild-type and CHD7 deficient (Chd7 (Whi/+) and Chd7 (Whi/Whi)) mouse embryos at day 9.5, a time point of neural crest cell migration. We identified 98 differentially expressed genes between wild-type and Chd7 (Whi/Whi) embryos. Interestingly, many misregulated genes are involved in neural crest cell and axon guidance such as semaphorins and ephrin receptors. By performing knockdown experiments for Chd7 in Xenopus laevis embryos, we found abnormalities in the expression pattern of Sema3a, a protein involved in the pathogenesis of Kallmann syndrome, in vivo. In addition, we detected non-synonymous SEMA3A variations in 3 out of 45 CHD7-negative CHARGE patients. In summary, we discovered for the first time that Chd7 regulates genes involved in neural crest cell guidance, demonstrating a new aspect in the pathogenesis of CHARGE syndrome. Furthermore, we showed for Sema3a a conserved regulatory mechanism across different species, highlighting its significance during development. Although we postulated that the non-synonymous SEMA3A variants which we found in CHD7-negative CHARGE patients alone are not sufficient to produce the phenotype, we suggest an important modifier role for SEMA3A in the pathogenesis of this multiple malformation syndrome.
Aramaki,
Phenotypic spectrum of CHARGE syndrome with CHD7 mutations.
2006, Pubmed
Aramaki,
Phenotypic spectrum of CHARGE syndrome with CHD7 mutations.
2006,
Pubmed
Bajpai,
CHD7 cooperates with PBAF to control multipotent neural crest formation.
2010,
Pubmed
,
Xenbase
Bergman,
CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype.
2011,
Pubmed
Borchers,
Xenopus cadherin-11 restrains cranial neural crest migration and influences neural crest specification.
2001,
Pubmed
,
Xenbase
Bosman,
Multiple mutations in mouse Chd7 provide models for CHARGE syndrome.
2005,
Pubmed
Chalouhi,
Olfactory evaluation in children: application to the CHARGE syndrome.
2005,
Pubmed
Dodé,
Kallmann syndrome.
2009,
Pubmed
Gammill,
Neural crest specification: migrating into genomics.
2003,
Pubmed
Hall,
The neural crest as a fourth germ layer and vertebrates as quadroblastic not triploblastic.
2000,
Pubmed
Hanchate,
SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.
2012,
Pubmed
Harland,
In situ hybridization: an improved whole-mount method for Xenopus embryos.
1991,
Pubmed
,
Xenbase
Hawker,
Two new mouse mutants with vestibular defects that map to the highly mutable locus on chromosome 4.
2005,
Pubmed
Hrabé de Angelis,
Genome-wide, large-scale production of mutant mice by ENU mutagenesis.
2000,
Pubmed
Huang,
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.
2009,
Pubmed
Huang,
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
2009,
Pubmed
Janssen,
Mutation update on the CHD7 gene involved in CHARGE syndrome.
2012,
Pubmed
Jongmans,
CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.
2009,
Pubmed
Jongmans,
CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene.
2006,
Pubmed
Kim,
Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
2008,
Pubmed
Kirby,
Factors controlling cardiac neural crest cell migration.
2010,
Pubmed
Koestner,
Semaphorin and neuropilin expression during early morphogenesis of Xenopus laevis.
2008,
Pubmed
,
Xenbase
Lalani,
Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation.
2006,
Pubmed
Morgan,
Ear-nose-throat abnormalities in the CHARGE association.
1993,
Pubmed
Ogata,
Kallmann syndrome phenotype in a female patient with CHARGE syndrome and CHD7 mutation.
2006,
Pubmed
Opitz,
Impact of RNA degradation on gene expression profiling.
2010,
Pubmed
Pinto,
CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development.
2005,
Pubmed
Randall,
Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice.
2009,
Pubmed
Sanlaville,
CHARGE syndrome: an update.
2007,
Pubmed
Sanlaville,
Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development.
2006,
Pubmed
Schwanzel-Fukuda,
Origin of luteinizing hormone-releasing hormone neurons.
1989,
Pubmed
Siebert,
Pathologic features of the CHARGE association: support for involvement of the neural crest.
1985,
Pubmed
Smith,
Injected Xwnt-8 RNA acts early in Xenopus embryos to promote formation of a vegetal dorsalizing center.
1991,
Pubmed
,
Xenbase
Teixeira,
Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions.
2010,
Pubmed
Van Meter,
Oculo-auriculo-vertebral spectrum and the CHARGE association: clinical evidence for a common pathogenetic mechanism.
1996,
Pubmed
Vissers,
Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.
2004,
Pubmed
Williams,
Speculations on the pathogenesis of CHARGE syndrome.
2005,
Pubmed
Wincent,
CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome.
2008,
Pubmed
Yazdani,
The semaphorins.
2006,
Pubmed
Young,
SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development.
2012,
Pubmed
